Treeline Biosciences
Treeline Biosciences raises $200M Series A
Quick Facts
Treeline Biosciences: Series A Funding Round
Treeline Biosciences has successfully raised $200M in Series A funding.
Company Overview
Developer of medicines for cancer and serious diseases, total funding $1.1B
Funding Details
The Series A round was led by Multiple investors.
Company Information
- Headquarters: Watertown, MA
- Founded: 2021
- Employees: 120+
- Category: HealthTech
Investment
Treeline Biosciences plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Multiple investors: Verified investor in Series A
Key Investors
About the Author
Related Company Reports
AccelerateStack Platform raises $75M Series C at $226M valuation
AccelerateStack Platform secures $75M in Series C funding led by Intel Capital, reaching $226M valuation as it accelerates growth in the healthtech sector.
DermaSensor raises $16M Series B at $85M valuation
DermaSensor raises $16M in Series B at $85M valuation. AI-powered skin cancer screening device for early detection...
Devoted Health Partners Headquarters - Office Location & Address
Discover Devoted Health Partners's headquarters at 100 2nd Ave, Waltham, MA 02451. Medicare Advantage insurance. Learn about the office facilities and work environment.
